rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1990-4-26
|
pubmed:abstractText |
Toxoplasmosis is a well-known problem under immunosuppressive conditions in cardiac transplant patients. In our series 12% of the patients (8 of 65) had clinical and/or serological signs of active toxoplasmosis. Due to its serious prognosis once the clinical process has started we favor a generous diagnostic interpretation of the serological results and a broad indication to drug therapy.
|
pubmed:language |
ger
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0040-5930
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
152-6
|
pubmed:dateRevised |
2008-2-12
|
pubmed:meshHeading |
|
pubmed:year |
1990
|
pubmed:articleTitle |
[Toxoplasmosis in the heart transplant patient].
|
pubmed:affiliation |
Kardiologie und Herzgefasschirurgie, Universitätsspital Zürich.
|
pubmed:publicationType |
Journal Article,
English Abstract
|